Search - tctmd.com

Displaying 881 - 900 of 1171

Sort: Relevancy | Date

News Daily News

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

Michael O'Riordan

February 23, 2017

Increased Radial Access Is Not Associated With Worse Femoral Outcomes for PCI in UK

News Daily News

High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry

Michael O'Riordan

February 17, 2017

News Daily News

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

Michael O'Riordan

February 16, 2017

News Daily News

HDL Function Improved With Olive Oil-Enriched Mediterranean Diet: PREDIMED Study

Michael O'Riordan

February 14, 2017

News Daily News

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

Michael O'Riordan

February 13, 2017

News Daily News

Alirocumab to Remain On Market While Companies Clash Over Patents

Michael O'Riordan

February 09, 2017

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

News Daily News

Edwards Lifesciences Pauses Transcatheter Mitral Valve Study to Work Out Design Issues

Michael O'Riordan

February 07, 2017

News Daily News

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Michael O'Riordan

February 03, 2017

News Daily News

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

Michael O'Riordan

February 03, 2017

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

News Daily News

Unique Scar in RVOT May Trigger Ventricular Tachycardia Seen in High-Level Endurance Athletes

Michael O'Riordan

January 31, 2017

News Daily News

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

Michael O'Riordan

January 26, 2017

News Daily News

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Michael O'Riordan

January 20, 2017

News Daily News

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Michael O'Riordan

January 18, 2017

News Daily News

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Michael O'Riordan

January 17, 2017

News Daily News

Global Burden of Elevated Systolic Blood Pressure on the Rise

Michael O'Riordan

January 10, 2017

News Daily News

Younger Adults With Severe Dyslipidemia Less Likely to Be Prescribed Statins

Michael O'Riordan

January 05, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

News Daily News

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Michael O'Riordan

December 19, 2016

Advertisement

Boston Scientific Recalls All Lotus Valves, Including Lotus With Depth Guard

High-Volume Transradial PCI Centers Do Not Lose Femoral Skills: BCIS Registry

DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed

HDL Function Improved With Olive Oil-Enriched Mediterranean Diet: PREDIMED Study

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

Alirocumab to Remain On Market While Companies Clash Over Patents

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Edwards Lifesciences Pauses Transcatheter Mitral Valve Study to Work Out Design Issues

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Major CVD Outcomes Trial Testing PCSK9 Inhibitor Evolocumab Meets Primary Endpoint

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Unique Scar in RVOT May Trigger Ventricular Tachycardia Seen in High-Level Endurance Athletes

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Less Than Half of ACS Patients Are Prescribed High-Potency Statin Therapy

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Global Burden of Elevated Systolic Blood Pressure on the Rise

Younger Adults With Severe Dyslipidemia Less Likely to Be Prescribed Statins

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content